Alnylam Pharmaceuticals Inc (ALNY)

307.99 +3.32 (+1.09%) USD  |  NASDAQ  |  Jun 13, 16:00
308.99 +1.00 (+0.32%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Total Long Term Debt (Quarterly): 1.026B for March 31, 2025

Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Debt Definition

View Total Long Term Debt Definition
Start Trial

Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Pfizer Inc 61.29B
BridgeBio Pharma Inc 1.848B
Axsome Therapeutics Inc 181.38M
BioMarin Pharmaceutical Inc 595.65M
Sarepta Therapeutics Inc 1.138B